Chris W

Chris W is a seasoned finance professional with extensive experience in the pharmaceutical industry and public accounting. As the VP Finance and Corporate Controller at Crinetics Pharmaceuticals since April 2025, Chris oversees financial operations. Prior to this role, Chris served as VP Corporate Controller at Revance from July 2020 to February 2025, where significant achievements included the merger announcement with Crown Labs, the launch of the DAXXIFY therapeutics business, and successful fundraising efforts. Chris's earlier experience includes leadership positions at PwC, where diverse industry exposure was gained while serving as an Assurance Senior Manager. Chris holds dual Bachelor's degrees in Business Administration (Accounting) and Vocal Performance and Piano from Washington State University.